Much information about the significance of VMAT2 in Parkinson’s disease was learned from studies conducted on mice that are heterozygous for VMAT2 [14] or VMAT2-deficient mice [15], where a decrease in the activity of the transporter was shown to be strongly related to Parkinson’s disease [16]. Here, SLC18A2 is linked to Parkinson disease.